Advertisement

Special Consideration of Brain Hypothermia Treatment for Subarachnoid Hemorrhage

  • Nariyuki Hayashi
  • Dalton W. Dietrich

Abstract

Brain hypothermia treatment is very effective for severe head trauma [13,15,17,19], postresuscitation of cardiac arrest [18,30], brain hypoxia [30], and occlusive cerebral stroke [9,11,30]. However, the effectiveness of brain hypothermia treatment for subarachnoid hemorrhage (SAH) is still controversial. The reason for the ineffectiveness of brain hypothermia treatment for SAH is the difficulty in controlling cerebral vasospasm under brain hypothermia. The diffuse vascular narrowing of cerebral vasospasm produces severe cerebral ischemia that is difficult to treat even with brain hypothermia management (Fig. 113). However, there are many questions about the relationships between the progression of cerebral vasospasm and brain hypothermia. The worsening of vasospasm by brain hypothermia, delayed progression of cerebral vasospasms during brain hypothermia, worsening of vasospasms after rewarming, good prognosis even with presence of diffuse vascular narrowing (Fig. 114), and poor prognosis without severe vasospasm are major clinical issues.

Keywords

Subarachnoid Hemorrhage Cerebral Vasospasm Basal Cistern Severe Hyperglycemia Severe Vasospasm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Almeida A, Delgado-Esteban M, Bolanos JP, Medina JM (2002) Oxygen and glucose deprivation induces mitochondrial dysfunction and oxidative stress in neurones but not in astrocytes in primary culture. J Neurochem 81: 207–217PubMedCrossRefGoogle Scholar
  2. 2.
    Baker AJ, Zornow MH, Scheller MS, Yaksh TL, Skilling SR, Smullin DH, Larson AA, Kuczenski R (1991) Changes in extracellular concentrations of glutamate, aspartate, glycine, dopamine, serotonin, and dopamine metabolites after transient global ischemia in the rat. J Neurochem 57:1370–1379PubMedCrossRefGoogle Scholar
  3. 3.
    Beck B (2000). Quantitative and macronutrient-related regulation of hypothalamic neuropeptide Y, galanin and neurotensin. In: Berthoud HR, Seeley RJ (eds) Neural and metabolic control of macronutrient intake, pp 455–464, CRC Press, Boca Raton New York Washington DCGoogle Scholar
  4. 4.
    Binnert C, Tappy L (2002) Microdialysis in the intensive care unit: a novel tool for clinical investigation or monitoring? Curr Opin Clin Nutr Metab Care 5:185–188PubMedCrossRefGoogle Scholar
  5. 5.
    Boels PJ, Verbeuren TJ, Vanhoutte PM (1985) Moderate cooling depresses the accumulation and the release of newly synthesized catecholamines in isolated canine saphenous veins. Experientia 41:1374–1377PubMedCrossRefGoogle Scholar
  6. 6.
    Clark LC Jr, Spokane RB, Hoffmann RE, Sudan R, Homan MM, Maloney AC, Jacobs SJ, Stroup TL, Winston PE (1988) Polarographic cerebral oxygen availability, fluorocarbon blood levels and efficacy of oxygen transport by emulsions. Biomater Artif Cells Artif Organs 16: 375–393PubMedGoogle Scholar
  7. 7.
    Clifton GL, Miller ER, Choi SC, Levin HS (2002) Fluid thresholds and outcome from severe brain injury. Crit Care Med 30:739–745PubMedCrossRefGoogle Scholar
  8. 8.
    Corte FD, Mancini A, Valle D, Gallizzi F, Carducci P, Mignani V, De Marinis L (1998) Provocative hypothalamopituitary axis tests in severe head injury: correlation with severity and prognosis. Crit Care Med 26:1419–1426PubMedCrossRefGoogle Scholar
  9. 9.
    Dempsey IRJ, Combs DJ, Maley ME, Cowen DE, Roy MW, Donaldson DL (1987) Moderate hypothermia reduces postischemic edema development and leukotriene production. Neurosurgery 21:177–181PubMedCrossRefGoogle Scholar
  10. 10.
    Dudariev VP, Lanovenko II (1999) Changes in the oxygen-binding properties of the blood in white rats under the influence of hypoxia and its pharmacological correction. Fiziol Zh 45:97–103PubMedGoogle Scholar
  11. 11.
    Han HS, Qiao Y, Karabiyikoglu M, Giffard RG, Yenari MA (2002) Influence of mild hypothermia on inducible nitric oxide synthase expression and reactive nitrogen production in experimetal stroke and inflammation. J Neurosci 22:3921–3928PubMedGoogle Scholar
  12. 12.
    Hayashi N (1995) Cerebral hypothermia treatment. In: Hayashi N (ed) Cerebral hypothermia treatment. Sogo Igaku, Tokyo, pp 1–105Google Scholar
  13. 13.
    Hayashi N (1997) Prevention of vegetation after severe head trauma and stroke by combination therapy of cerebral hypothermia and activation of immunedopaminergic nervous system. Proc Soc Treat Coma 6:133–145Google Scholar
  14. 14.
    Hayashi N (2000) Enhanced neuronal damage in severely brain injured patients by hypothalamus, pituitary, and adrenal axis neuro-hormonal changes. In: Hayashi N (ed) Brain hypothermia. Springer, Berlin Heidelberg New York Tokyo, pp 3–26CrossRefGoogle Scholar
  15. 15.
    Hayashi N (2000) The clinical issue and effectiveness of brain hypothermia treatment for severe brain injured patients. In: Hayashi N (ed) Brain hypothermia. Springer, Berlin Heidelberg New York Tokyo, pp 121–151CrossRefGoogle Scholar
  16. 16.
    Hayashi N, Hirayama T, Utagawa T, Ohata M (1994) Systemic management of cerebral edema based on a new concept in severe head injury patients. Acta Neurochir [Suppl] 60:541–543Google Scholar
  17. 17.
    Hayashi N, Utagawa A, Kinosita K, Izumi T (1999) Application of a novel technique for clinical evaluation of nitric oxide-induced free radical reactions in ICU patients. Cell Mol Neurobiol 19:3–17PubMedCrossRefGoogle Scholar
  18. 18.
    Hayashi N, Nagso K, Utagawa A, Sakurai A (2001) The push back of life edge from cardiac death by combination therapy with percutaneous cardiopulmonary support and brain hypothermia treatment in cardiac arrested patients. Cardiovasc Med Surg 3:68–77Google Scholar
  19. 19.
    Jiang JY, Lyeth BG, Kapasi MZ, Jenkins LW, Povlishock JT (1992) Moderate hypothermia reduces blood-brain barrier disruption following traumatic brain injury in the rat. Acta Neuropathol (Berl) 84:495–500CrossRefGoogle Scholar
  20. 20.
    Kagawa M, Nagao S, Bemana I (1996) Arginine vasopressin receptor antagonists for treatment of vasogenic brain edema: an experimental study. J Neurotrauma 13:273–279PubMedCrossRefGoogle Scholar
  21. 21.
    Kossmann T, Hans V, Imhof HG, Stocker R, Grob P, Trentz O, Morgani-Kossmann MC (1995) Intrathecal and serum interleukin-6 and acute-phase response in patients with severe traumatic brain injuries. Shock 4:311–317PubMedCrossRefGoogle Scholar
  22. 22.
    Kow LM, Pfaff DW (1986) Vasopressin excites ventromedial hypothalamus glucose-responsive neurons in vitro. Physiol Behav 37:153–158PubMedCrossRefGoogle Scholar
  23. 23.
    Leibowitz SF (1999) Macronutrients and brain peptides: what they do and how they respond. In: Berthoud HR, Seeley RJ (eds) Neural and metabolic control of macronutrient intake. CRC Boca Raton, pp 389–406Google Scholar
  24. 24.
    Leibowiz SF, Sladek C, Spencer L, Temple D (1988) Neuropeptide Y, epinephrine and norepinephrine in the paraventricular nucleus: stimulation of feeding and the release of corticosterone, vasopressin and glucose. Brain Res Bull 21:905–912CrossRefGoogle Scholar
  25. 25.
    Lin TW, Kuo YS (1996) Acute pulmonary oedema following administration of vasopressin for control of massive GI tract haemorrhage in a major burn patient. Burns 22:73–75PubMedCrossRefGoogle Scholar
  26. 26.
    Lindley RI (2000) Drug therapy for acute ischemic stroke: risks verusus benefits. In: Prakash A (ed) Acute stroke treatment. Adis, Hong Kong, pp 53–62 FoundationGoogle Scholar
  27. 27.
    Macintosh TK, Hayes R, DeWitt D, Agura V, Faden Al (1987) Endogenous opioids may mediate secondary damage after experimental brain injury. Am J Physiol 258:E565–574Google Scholar
  28. 28.
    McClain CJ, Hennig B, Ott L, Goldblum S, Young AB (1988) Mechanisms and implications of hypoalbuminemia in head-injured patients. J Neurosurg 69:386–392PubMedCrossRefGoogle Scholar
  29. 29.
    Morgan TJ, Koch D, Morris D, Clague A, Purdie DM (2001) Reduced red cell 2,3-diphosphoglycerate concentrations in critical illness without decreased in vivo P50. Anaesth Intensive Care 29:479–483PubMedGoogle Scholar
  30. 30.
    Nagao K, Hayashi N, Kanmatsuse K, Arima K, Ohtsuki J, Kikushima K, Watanabe I (2000) Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital. J Am Coll Cardiol 36:776–783PubMedCrossRefGoogle Scholar
  31. 31.
    Nilsson OG, Saveland H, Boris-Moller F, Brandt L, Wieloch T (1996) Increased levels of glutamate in patients with subarachnoid haemorrhage as measured by intracerebral microdialysis. Acta Neurochir Suppl 67:45–47PubMedGoogle Scholar
  32. 32.
    Payne LC, Obal F Jr, Opp MR, Krueger JM (1992) Stimulation and inhibition of growth hormone secretion by IL1: the involvement of growth hormone. Neuroendoclinology 56:118–123CrossRefGoogle Scholar
  33. 33.
    Rosomoff HL (1959) Protective effects of hypothermia against pathological processes of the nervous system. Ann NY Acad Sci 80:475–486PubMedCrossRefGoogle Scholar
  34. 34.
    Sahuquillo J, Amoros S, Santos A, Poca MA (2000) Does an increase in cerebral perfusion pressure always mean a better oxygenated brain? A study in head-injured patients. Acta Neurochir Suppl 76:457–462PubMedGoogle Scholar
  35. 35.
    Silvka A, Coben G (1985) Hydroxyl radical attack on dopamine. J Biol Chem 260:15466–15472Google Scholar
  36. 36.
    Stanley BG (1993) Neuropeptide Y in multiple hypothalamic sites controls eating behavior, endocrine, and autonomic system for body energy balance. In: Colmers WF, Wahlestedt C (eds) Biology of neuropeptide Y and related peptide. Humana Press, Totowa, NJ, pp 457–509CrossRefGoogle Scholar
  37. 37.
    Temple DL, Leibowitz SF (1994) The neuropeptide Y system (hypothalamus) has a dense concentration of glucocorticoide (type II) receptors that mediate carbon hydrate intake. J Neuroendocrinol 6:479–501CrossRefGoogle Scholar

Copyright information

© Springer Japan 2004

Authors and Affiliations

  • Nariyuki Hayashi
    • 1
    • 2
  • Dalton W. Dietrich
    • 3
    • 4
  1. 1.Nihon University Emergency Medical CenterTokyoJapan
  2. 2.Department of Emergency and Critical Care MedicineNihon University School of MedicineTokyoJapan
  3. 3.Department of Neurological Surgery, Neurology and Cell Biology and AnatomyUniversity of Miami School of MedicineMiamiUSA
  4. 4.The Miami Project to Cure ParalysisMiamiUSA

Personalised recommendations